@article{ATM30326,
author = {Shingo Kato and Kazufumi Honda},
title = {CA19-9 as a therapeutic target in pancreatitis},
journal = {Annals of Translational Medicine},
volume = {7},
number = {Suppl 8},
year = {2019},
keywords = {},
abstract = {The glycan carbohydrate antigen 19-9 (CA19-9) is one of the most important and widely used biomarkers for pancreatic cancer. In 1979, Koprowski et al. first described CA 19-9 as a tumor antigen recognized by the monoclonal antibody NS19-9 (1).},
issn = {2305-5847}, url = {https://atm.amegroups.org/article/view/30326}
}